Cargando…
Multiomic characterization of disease progression in mice lacking dystrophin
Duchenne muscular dystrophy (DMD) is caused by genetic mutations leading to lack of dystrophin in skeletal muscle. A better understanding of how objective biomarkers for DMD vary across subjects and over time is needed to model disease progression and response to therapy more effectively, both in pr...
Autores principales: | Signorelli, Mirko, Tsonaka, Roula, Aartsma-Rus, Annemieke, Spitali, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065259/ https://www.ncbi.nlm.nih.gov/pubmed/37000843 http://dx.doi.org/10.1371/journal.pone.0283869 |
Ejemplares similares
-
Plasma lipidomic analysis shows a disease progression signature in mdx mice
por: Tsonaka, Roula, et al.
Publicado: (2021) -
Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models
por: Tsonaka, Roula, et al.
Publicado: (2020) -
Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice
por: Spitali, Pietro, et al.
Publicado: (2013) -
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients
por: Signorelli, Mirko, et al.
Publicado: (2021) -
Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high‐dimensional data
por: Signorelli, Mirko, et al.
Publicado: (2021)